EFFECTIVENESS OF REAL-TIME PCR FOR EXPRESS FIRST LINE DRUG SUSCEPTIBILITY TESTING OF TUBERCULOUS MYCOBACTERIA USING SPUTUM SAMPLES AND SURGICAL SPECIMENS OF LUNG TISSUE
https://doi.org/10.21292/2075-1230-2018-96-12-18-24
Abstract
The objective of the study: to investigate the effectiveness of real-time PCR for express drug susceptibility testing in drug resistant pulmonary tuberculosis patients using sputum samples and specimens of lung tissue collected during surgery.
Subjects and methods. 231 sputum samples and 240 biopsy specimens collected during surgery were tested with the use of real-time PCR and multi-competitive allele-specific real-time PCR.
Results: the positive results of testing for MTB DNA were obtained in 72.7% of respiratory samples, of which in 61.9%, the number of genomic DNA copies was sufficient for drug susceptibility testing; positive results were observed in 93.3% of biopsy specimens, and in 93% of them the drug resistance of tuberculous mycobacteria was tested. The difference in the effectiveness of drug susceptibility testing of biopsy specimens and respiratory samples was statistically significant: p < 0.01. When testing respiratory samples, multiple drug resistance (MDR) was detected in 42.3% of cases, and when testing biopsy specimens, MDR was detected in 34.4% of cases. The high effectiveness of real-time PCR and multi-competitive allele-specific real-time PCR was demonstrated when testing biopsy specimens and performing express drug susceptibility testing in tuberculosis patients after surgical treatment.
About the Authors
Yu. S. Alyapkina
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
OOO Sintol, Moscow
Russian Federation
Russian Federation
Doctoral Student
4, Dostoevsky St., Moscow, 127473
Phone: +7 (495) 681-74-32
A. A. Elov
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
Russian Federation
Russian Federation
Leading Researcher.
4, Dostoevsky St., Moscow, 127473
Phone: +7 (495) 681-96-03
L. K. Shipina
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
Russian Federation
Russian Federation
Senior Researcher.
4, Dostoevsky St., Moscow, 127473
Phone: +7 (495) 681-96-03
M. A. Vladimirskiy
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
Russian Federation
Russian Federation
Head of Infectious Immunology and Biotechnology Laboratory.
4, Dostoevsky St., Moscow, 127473
Phone: +7 (495) 681-74-32.
References
1. Аlyapkina Yu.S., Аlekseev Ya.I., Varlamov D.А., Domotenko L.V., Shipina L.K., Vladimirskiy M.А. Development of real time PCR technology for rapid drug susceptibility testing of tuberculous mycobacteria to second line drugs: fluoruquinolones, amikacin, capreomicin. Tuberculosis and Lung Diseases, 2014, no. 12, pp. 69-75. (In Russ.)
2. Аlyapkina Yu.S., Larionova E.E., Smirnova T.G., Аlekseev Ya.I., Chernousova L.N., Vladimirskiy M.А. Investigation of ranges and frequency of mutations in the embB gene in Mycobacterium tuberculosis associated with resistance to ethambutol using real-time polymerase chain reaction. Tuberculosis and Lung Diseases, 2017, no. 11, pp. 27-35. (In Russ.)
3. Vladimirskiy M.А., Аlyapkina Yu.S., Varlamov D.А., Аlekseev Ya.I. et al. Use of real-time PCR for detection and monitoring of transmission of drug resistant strains of tuberculous mycobacteria. Probl. Tub., 2008, no. 4, pp. 38-44. (In Russ.)
4. Urbakh V.Yu. Statisticheskiy analiz v biologicheskikh i meditsinskikh issledovaniyakh. [Statistic analysis in biological and medical research]. Moscow, 1975, pp. 162.
5. Abanda N.N., Djiengoue J., Lim E. et al. Diagnostic accuracy and usefulness of the Genotype MTBDR plus assay in diagnosing multidrug resistant tuberculosis Cameroon. Cross-sectional study. BMC Infectious Diseases, 2017, vol. 17, pp. 379.
6. Alyapkina Yu.S., Vladimirsky M.A., Varlamov D.A., Alekseev J.I., Shipina L.K. Rapid detection of M. tuberculosis gene mutations associated with drug resistance by modified allele-specific real-time PCR. Abstracrs 16-th ERS Annual Congress, September 2006. Europ. Resp. J., 2006, vol. 28, suppl. 50, pp. 3456.
7. Steingart K.R., Schiller I., Horne D.J., Pai M., Boehme C.C., Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review). Cochrane Database Syst. Rev., 2014, no. 1, pp. 1-166.
8. Walker T.M., Kohl Th.A., Omar Sh.V., Hedge J. et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect. Dis., 2015, vol. 15, pp. 1193-1202.
Review
For citations:
Alyapkina Yu.S., Elov A.A., Shipina L.K., Vladimirskiy M.A. EFFECTIVENESS OF REAL-TIME PCR FOR EXPRESS FIRST LINE DRUG SUSCEPTIBILITY TESTING OF TUBERCULOUS MYCOBACTERIA USING SPUTUM SAMPLES AND SURGICAL SPECIMENS OF LUNG TISSUE. Tuberculosis and Lung Diseases. 2018;96(12):18-24. (In Russ.) https://doi.org/10.21292/2075-1230-2018-96-12-18-24
Views:
1220
Email this article 